Pre-AIDS deaths in HIV infection related to intravenous drug use

QJM: An International Journal of Medicine

Volumn 90, Issue 10, 1997, Pages 617-629

  Brettle, R P ^a   Chiswick, A ^a   Bell, J ^b   Busuttil, A ^c   Wilson, A ^a   Povey, S ^a   Leen, C L S ^a  

^a CITY HOSPITAL   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOPSY; CAUSE OF DEATH; DEATH; DISEASE CLASSIFICATION; DRUG OVERDOSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEPSIS;

EID: 0030679683     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/90.10.617     Document Type: Article

References (40)

1. Stoneburner RL, Des Jarlais DC, Benezra D, et al. A larger spectrum of severe HIV-1 related disease in intravenous drug users in New York City. Science 1989; 242:916-18.
2. Selwyn PA, Alcabes P, Hartel D, Buono D, Schoenbaum E, Klein RS, Davenny K, Friedland GH. Clinical manifestations and predictors of disease progression in drug users with HIV infection. N Engl J Med 1992; 327:1697-703.
3. van Haastrecht HJA, van den Hock AR, Coutinho RA. High mortality among HIV infected injecting drug users without AIDS diagnosis: implications for HIV infection epidemic modellers? AIDS 1994; 8:363-6.
4. Brettle RP, Foreman A, Povey S. Clinical features of early HIV in the Edinburgh City Hospital Cohort. Int J STD AIDS 1996; 7:110-16.
5. Louria DB, Hensle T, Rose J. The major medical complications of heroin addiction. Ann Intern Med 1967; 67:1-22.
6. Ritson AB, Plant MA. Drugs and Young People in Scotland. Edinburgh, Scottish Health Education Unit, 1977.
7. Robertson JR, Bucknall AB. Heroin users in a Scottish City - Edinburgh Drug Addiction Study. West Granton Medical Group, 1 Muirhouse Avenue, Edinburgh EH4 4PL, 1986.
8. Waldorf D, Biernachie PJ. Natural recovery from heroin addiction: a review of the incidence literature. J Drug Issues 1979; 9:281-9.
9. Wille R. Processes of recovery from heroin dependence: relationship to treatment social change and dry use. J Drug Issues 1983; 13:333-42.
10. Zaccarelli M, Gattari P, Rezza G, Conti S, Spizzichino L, Vlahov D, et al. Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS 1994; 8:345-50.
11. Galli M, Musicco M, for the COMCAT study group. Mortality of intravenous drug users living in Milan, Italy: role of HIV infection. AIDS 1994; 8:1457-63.
12. Fugelstad A, Rajs J, Bottiger M, Gerhardsson de Verdier M. Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatment. Addiction 1995; 90:711-16.
13. van Haastrecht HJ, van Ameijden EJ, van den Hoek JA, Mientjes GH, Bax JS, Coutinho RA. Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users. Am J Epidemiol 1996; 143:380-91.
14. Eskild A, Magnus P, Sohlberg C, Kittelsen P, Giving JH, Teige B, Skullerud K. Slow progression to AIDS in intravenous drug users infected with HIV in Norway. J Epidemiol Community Health 1994; 48:383-7.
15. Chitwood DD, Comerford M, McBride DC, Chitwood JS, McCoy CB, Weatherby NL. The impact of HIV infection on mortality of injection drug users. Abstract Tu.C.2539. XIth International Conference on AIDS, Vancouver BC, 1996.
16. Poole WK, Fulkerson W, Lou Y, Kvale P, Hopewell PC, Hirschtick R, et al. Overall and cause specific mortality in a cohort of homo/bisexual men, injecting drug users, and female partners of HIV-infected men. AIDS 1996; 10:1257-64.
17. Brettle RP, Gore SM, Bird AG, McNeil AJ. Clinical and epidemiological implications of CDC/WHO reclassification of AIDS cases. AIDS 1993; 7:531-9.
18. Brettle RP, McNeil AJ, Gore SM, Bird AG, Richardson A. Analysis of enrolment, progression, survival, mortality and descriptive covariates in the Edinburgh City Hospital Cohort. Q J Med 1995; 88:479-91.
19. Selwyn PA, Hartel D, Wasserman W, Drucker E. Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health 1989; 79:1358-62.
20. Mientjes GH, van Ameijden EJ, van den Hoek AJAR, Coutinho RA. Increasing morbidity without rise in non-AIDS mortality among HIV-infected intravenous drug users in Amsterdam. AIDS 1992; 6:207-12.
21. Brettle RP, Gore SM, McNeill A. Outpatient medical care of injection drug use related HIV. Int J STD AIDS 1992; 3:96-100.
22. Brettle RP, Willocks L, Hamilton BA, et al. Out patient medical care in Edinburgh for IDU related HIV. AIDS Care 1994; 6:49-58.
23. Brettle RP, McNeil AJ, Gore SM, Bird AG, Leen CSL, Richardson A. Analysis of enrolment, progression, survival, mortality and descriptive covariates in the Edinburgh City Hospital Cohort. Q J Med 1995; 88:479-91.
24. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Mortality Morbidity Weekly Report 1987; 36:3S-15S
25. Centers for Disease Control. Review of draft for revision of HIV infection classification system and expansion of AIDS surveillance case definition. Mortality Morbidity Weekly Report 1991; 40:787.
26. Park RAA. European AIDS definition. Lancet 1992; 339:671.
27. Burns S, Brettle RP, Gore SM, Peutherer J, Robertson JR. Epidemiology of injection drug use related HIV in Edinburgh: a historical perspective and new insight on past HIV incidence from the retrospective HIV testing of stored sera. J Infect 1996; 32:53-62.
28. Seaman S, Brettle RP, Gore SM. Pre-AIDS mortality in the Edinburgh City Hospital HIV Cohort. Statistics in Medicine 1997; in press.
29. Prins M, Aguado IH, Brettle RP, Robertson JR, Hirschel B, Carre N, et al. Pre-AIDS mortality from natural causes associated with HIV disease progression; Evidence from the European Seroconverter Study among injecting drug users. In preparation.
30. Gore SM, Brettle RP, Burns SM, Lewis SC. Pilot study to estimate survivors to 1995 of 1983-84 prevalent Hepatitis C infections in Lothian patients tested for Hepatitis B surface antigen in 1983-84. QJM (submitted). [query authors]
31. van Ameijden EJC, van Den Hoek JAR, mientjes GHC, Coutinho RA. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol 1993; 9:255-62.
32. Jones ME, Brettle RP, Busuttil A, Inglis MH, Bell JE, Willocks L. Sudden death in HIV infected drug user. Presumptive overdose in an HIV positive narcotic addict. J Infect 1993; 27:79-81.
33. Bell JE, Busuttil A, Ironside JW, et al. Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J Infect Dis 1993; 168:818-24.
34. Gray F, Hurtrel M, Hurtrel B. Early central nervous system changes in human immunodeficiency virus (HIV) infection. Neuropath Appl Neurobiol 1993; 19:3-9.
35. Beck EJ, Kennelly J, McKevitt C, Whitaker L, Wadsworth J, Miller DL, et al. Changing presentation and survival, service utilisation and costs for AIDS patients: insights from a London referral centre. AIDS 1994; 8:379-84.
36. Beck EJ, Kennelly J, McKevitt C, Whitaker L, Wadsworth J, Miller DL, et al. Changing use of hospital services and costs at a London AIDS referral centre, 1983-1989. AIDS 1994; 8:367-77.
37. Nageswaran A, Kinghorn GR, Shen RN, Priestley CJF, Kyi TT. Hospital service utilization by HIV/AIDS patients and their management cost in a provincial genitourinary medicine department. Int J STD AIDS 1995; 6:336-44.
38. Brettle RP, Atkinson FI, Wilcock J, Richardson A, Lewis R, MacCallum L, Bath G. Hospital and hospice resource use of HIV positive patients in Edinburgh. Int J STD AIDS 1997; 8:234-42.
39. Willocks L, Cowan FM, Brettle RP, Emmanuel FXS, Flegg PJ, Burns S. The spectrum of chest infections in HIV positive patients in Edinburgh. J Infect 1992; 24:37-42.
40. Selwyn PA, Alcabes P, Hartel D, Buono D, Schoenbaum EE, Klein RS, Davenny K, Friedland GH. Clinical manifestations and predictors of disease progression in drug users with HIV infection. N Engl J Med 1992; 327:1697-703.